April 2018

7 tests for assessing cognition in early Alzheimer’s disease

Insights Back to resource centre 27 April 2018 7 tests for assessing cognition in early Alzheimer’s disease With rising life-expectancy, the number of cases of dementia and related disorders is increasing. In attempts to tackle the pandemic, treatment trials are moving earlier in the disease process. CANTAB offers a battery of tests specially targeted at assessing cognition in early Alzheimer’s

7 tests for assessing cognition in early Alzheimer’s disease Read More »

A solution for improving recruitment into early Alzheimer’s disease clinical trials

Insights Back to resource centre 12 April 2018 A solution for improving recruitment into early Alzheimer’s disease clinical trials Screening patients into early stage Alzheimer’s trials can be costly and time-consuming. Kenton Zavitz, PhD, Director of Clinical Affairs proposes a potential solution for improving recruitment into clinical trials. Key pointsScreening patients into early Alzheimer’s trials can be costly and time-consuming.Screening

A solution for improving recruitment into early Alzheimer’s disease clinical trials Read More »

The challenge of detecting early Alzheimer’s disease for clinical trials

Insights Back to resource centre 9 April 2018 The challenge of detecting early Alzheimer’s disease for clinical trials In this post, Director of Clinical Affairs, Dr Kenton Zavitz, looks at the challenge of recruiting the correct patients into Alzheimer’s disease trials. Key PointsAlzheimer’s disease (AD) is a global healthcare and economic crisis.Despite hundreds of clinical trials of new AD treatments,

The challenge of detecting early Alzheimer’s disease for clinical trials Read More »

Affective face processing in schizophrenia: disorder-specific or transdiagnostic deficit

Affective face processing in schizophrenia: disorder-specific or transdiagnostic deficit?

Insights Back to resource centre 6 April 2018 Affective face processing in schizophrenia: disorder-specific or transdiagnostic deficit? Our recent review of meta-analyses concluded that facial emotion recognition deficits are common across a range of psychiatric, neurological and developmental disorders. Our Senior Scientist, Dr Jack Cotter, presented the latest findings at Schizophrenia International Research Society (SIRS) conference. BackgroundSocial cognitive dysfunction is

Affective face processing in schizophrenia: disorder-specific or transdiagnostic deficit? Read More »

Scroll to Top